US FDA Approves Sale of Six on! PLUS Nicotine Pouch Products

Post by : Saif

The United States Food and Drug Administration (FDA) has given permission for six nicotine pouch products to be sold legally in the country. The products belong to the on! PLUS brand, which is owned by Altria, one of the largest tobacco companies in the United States.

The FDA announced the decision on Friday, saying the products were approved under a new pilot program designed to speed up the review process for certain tobacco-related products. This marks the first time the FDA has granted market authorization through this fast-track system.

The approved products are six on! PLUS nicotine pouches made by Helix Innovations LLC, a joint venture owned by Altria. The company applied for approval in June 2024, and the FDA completed its review in just over a year.

The authorization allows these nicotine pouches to be sold to adults in the United States. The products come in mint, tobacco, and wintergreen flavors and are available in two nicotine strengths: 6 milligrams and 9 milligrams.

According to the FDA, its decision was based on scientific evidence showing that these products contain lower levels of harmful chemicals than traditional smokeless tobacco. Because of this, the agency said they pose a lower risk of cancer and other serious health problems compared to other non-smoking tobacco products.

The FDA made it clear that the approval applies only to the six specific on! PLUS products reviewed. Other nicotine products made by Helix Innovations or Altria are not covered by this decision and would need separate approval.

Nicotine pouches are small, smokeless products placed under the upper lip. They do not involve burning or inhaling smoke and do not contain tobacco leaf. Because of this, they are often seen as one of the lowest-risk alternatives for adult smokers who want to avoid cigarettes.

In recent years, nicotine pouches have become the fastest-growing category of tobacco-related products in the United States. Many adults are turning to these products as cigarette smoking continues to decline.

Earlier this year, the FDA approved 20 Zyn nicotine pouch products, which are owned by Philip Morris International. That decision marked the first time any nicotine pouch products received FDA market authorization in the U.S. However, Zyn’s approval came more than five years after the company first applied.

Tobacco companies have been investing heavily in smoke-free products as public health rules become stricter and smoking rates fall. Companies argue that offering alternatives with lower health risks can help adult smokers move away from cigarettes.

Following the FDA’s decision, Altria said it will restart taking new orders for on! PLUS products in several states, including Florida, North Carolina, and Texas. The company also plans to sell the products again through online platforms.

Health experts, however, continue to warn about nicotine use, especially among young people. The U.S. Centers for Disease Control and Prevention says nicotine can harm brain development in adolescents, affecting attention, learning, mood, and impulse control.

For this reason, the FDA stressed that the approved products are only meant for adult users and should not be used by children or teenagers. The agency continues to monitor how these products are marketed and sold.

The FDA’s decision highlights the ongoing debate between harm reduction for adult smokers and the need to protect young people from nicotine addiction. As more smoke-free products enter the market, regulators will face increasing pressure to balance these two goals.

#trending #latest #FDA #NicotinePouches #onPLUS #Altria #PublicHealth #TobaccoRegulation #SmokingAlternatives